Frontlight ResearchEarly access
Osteoporosis trials in Japan
2 of 3 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleRESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
- Where
- Akita, Bunkyō-Ku, Fukuoka, Iwata, Izunokuni, Kawasaki, Kawasaki-shi, Kochi, Kōriyama, Kumamoto, Marugame, Nishinomiya, Okayama, Saga, Shizuoka
- Age
- 65 years to 91 years
- People
- 2,400 worldwide
- Run by
- AgNovos Healthcare, LLC
See details and how to joinNCT04796350 - Phase 2Taking peopleExamination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients
- Where
- Matsumoto
- Age
- 20 years to 120 years
- People
- 90
- Run by
- Shinshu University
See details and how to joinNCT03755193